Diabetic Neuropathy, Painful Withdrawn Phase 1 / 2 Trials for Benfotiamine (DB11748)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01793350Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral NeuropathyTreatment